These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 22082137
1. The use of botulinum toxins for the management of chronic pain and headache: making the most of an evidence-based medicine approach for these rapidly evolving treatments. Argoff CE. Pain Med; 2011 Nov; 12(11):1581-2. PubMed ID: 22082137 [No Abstract] [Full Text] [Related]
2. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles. Laskin DM. Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341 [Abstract] [Full Text] [Related]
3. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections? Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group. Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970 [Abstract] [Full Text] [Related]
4. An update on botulinum toxin A injections of trigger points for myofascial pain. Zhou JY, Wang D. Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700 [Abstract] [Full Text] [Related]
5. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials. Leonardi G, Alito A, Portaro S, Di Matteo B, Respizzi S, Kon E, Massazza G, Sconza C. Eur J Pain; 2024 Mar; 28(3):369-381. PubMed ID: 37950343 [Abstract] [Full Text] [Related]
7. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome. Desai MJ, Shkolnikova T, Nava A, Inwald D. Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187 [Abstract] [Full Text] [Related]
8. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review. Ho KY, Tan KH. Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119 [Abstract] [Full Text] [Related]
9. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain. Adelowo A, Hacker MR, Shapiro A, Modest AM, Elkadry E. Female Pelvic Med Reconstr Surg; 2013 Jul; 19(5):288-92. PubMed ID: 23982578 [Abstract] [Full Text] [Related]
10. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Ojala T, Arokoski JP, Partanen J. Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597 [Abstract] [Full Text] [Related]
13. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Wheeler AH, Goolkasian P, Gretz SS. Spine (Phila Pa 1976); 1998 Aug 01; 23(15):1662-6; discussion 1667. PubMed ID: 9704373 [Abstract] [Full Text] [Related]
14. Treatment of refractory pain with botulinum toxins--an evidence-based review. Jabbari B, Machado D. Pain Med; 2011 Nov 01; 12(11):1594-606. PubMed ID: 21958302 [Abstract] [Full Text] [Related]
15. Safety and Efficacy of PrabotulinumtoxinA (Nabota®) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study. Kim DY, Kim JM. Toxins (Basel); 2018 Sep 03; 10(9):. PubMed ID: 30177597 [Abstract] [Full Text] [Related]
16. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. De Andrés J, Adsuara VM, Palmisani S, Villanueva V, López-Alarcón MD. Reg Anesth Pain Med; 2010 Sep 03; 35(3):255-60. PubMed ID: 20921836 [Abstract] [Full Text] [Related]
17. Intra-articular knee joint Botox injection for chronic osteoarthritic pain. Goyal N. Anaesth Intensive Care; 2008 Jan 03; 36(1):123. PubMed ID: 18326148 [No Abstract] [Full Text] [Related]
18. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain. Castiglione A, Bagnato S, Boccagni C, Romano MC, Galardi G. Arch Phys Med Rehabil; 2011 Jul 03; 92(7):1034-7. PubMed ID: 21704782 [Abstract] [Full Text] [Related]
19. Botulinum toxin type A therapy in chronic pain disorders. Lang AM. Arch Phys Med Rehabil; 2003 Mar 03; 84(3 Suppl 1):S69-73; quiz S74-5. PubMed ID: 12708561 [Abstract] [Full Text] [Related]
20. Botulinum toxin type A in refractory chronic migraine: an open-label trial. Menezes C, Rodrigues B, Magalhães E, Melo A. Arq Neuropsiquiatr; 2007 Sep 03; 65(3A):596-8. PubMed ID: 17876397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]